Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Oct;81(4):690–695. doi: 10.1038/sj.bjc.6690749

In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6

V Speirs 1, D S Walton 1, M-C Hall 1, S L Atkin 1
PMCID: PMC2362898  PMID: 10574257

Abstract

Enzymes modulating local steroid availability play an important role in the progression of human breast cancer. These include isoforms of 17β-hydroxysteroid dehydrogenase (17-HSD), aromatase and steroid sulphatase (STS). The aim of this study was to investigate the expression, by reverse transcription polymerase chain reaction, of 17-HSD types I–IV, aromatase and steroid STS in a series of 51 human breast tumour biopsies and 22 primary cultures of epithelial and stromal cells derived from these tumours, giving a profile of the steroid-regulating network for individual tumours. Correlations between enzyme expression profiles and expression of the interleukin (IL)-6 gene were also sought. All except one tumour expressed at least one isoform of 17-HSD, either alone or in combination with aromatase and STS. Expression of 17-HSD isoforms I–IV were observed in nine tumours. Of the 15 tumours which expressed three isoforms, a combination of 17-HSD II, III and IV was most common (6/15 samples). The majority of tumours (n = 17) expressed two isoforms of 17-HSD with combinations of 17-HSD II and IV predominant (7/17 samples). Eight tumours expressed a single isoform and of these, 17-HSD I was in the majority (5/8 samples). In primary epithelial cultures, enzyme expression was ranked: HSD I (86%) > STS (77%) > HSD II (59%) > HSD IV (50%) = aromatase (50%) > HSD III (32%). Incidence of enzyme expression was generally reduced in stromal cultures which were ranked: HSD I (68%) > STS (67%) > aromatase (48%) > HSD II (43%) > HSD IV (28%) > HSD III (19%). Expression of IL-6 was associated with tumours that expressed ≥ 3 steroid-converting enzymes. These tumours were of higher grade and tended to come from patients with family history of breast cancer. In conclusion, we propose that these enzymes work in tandem with cytokines thereby providing sufficient quantities of bioactive oestrogen from less active precursors which stimulates tumour growth. © 1999 Cancer Research Campaign

Keywords: breast cancer, steroids, interleukin-6

Full Text

The Full Text of this article is available as a PDF (83.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams E. F., Rafferty B., White M. C. Interleukin 6 is secreted by breast fibroblasts and stimulates 17 beta-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17 beta-oestradiol levels. Int J Cancer. 1991 Aug 19;49(1):118–121. doi: 10.1002/ijc.2910490122. [DOI] [PubMed] [Google Scholar]
  2. Adamski J., Normand T., Leenders F., Monté D., Begue A., Stéhelin D., Jungblut P. W., de Launoit Y. Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. Biochem J. 1995 Oct 15;311(Pt 2):437–443. doi: 10.1042/bj3110437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andersson S. 17 beta-hydroxysteroid dehydrogenase: isozymes and mutations. J Endocrinol. 1995 Aug;146(2):197–200. doi: 10.1677/joe.0.1460197. [DOI] [PubMed] [Google Scholar]
  4. Boyle-Walsh E., Birch M., Gallagher J. A., Speirs V., White M. C., Shenkin A., Fraser W. D. RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas. J Pathol. 1996 Apr;178(4):442–446. doi: 10.1002/(SICI)1096-9896(199604)178:4<442::AID-PATH521>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  5. Casey M. L., MacDonald P. C., Andersson S. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest. 1994 Nov;94(5):2135–2141. doi: 10.1172/JCI117569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Castagnetta L. A., Carruba G., Traina A., Granata O. M., Markus M., Pavone-Macaluso M., Blomquist C. H., Adamski J. Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells. Endocrinology. 1997 Nov;138(11):4876–4882. doi: 10.1210/endo.138.11.5497. [DOI] [PubMed] [Google Scholar]
  7. Corbould A. M., Judd S. J., Rodgers R. J. Expression of types 1, 2, and 3 17 beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J Clin Endocrinol Metab. 1998 Jan;83(1):187–194. doi: 10.1210/jcem.83.1.4495. [DOI] [PubMed] [Google Scholar]
  8. Deyashiki Y., Ohshima K., Nakanishi M., Sato K., Matsuura K., Hara A. Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase (A-specific), a member of the aldoketoreductase family. J Biol Chem. 1995 May 5;270(18):10461–10467. doi: 10.1074/jbc.270.18.10461. [DOI] [PubMed] [Google Scholar]
  9. Elo J. P., Akinola L. A., Poutanen M., Vihko P., Kyllönen A. P., Lukkarinen O., Vihko R. Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer. 1996 Mar 28;66(1):37–41. doi: 10.1002/(SICI)1097-0215(19960328)66:1<37::AID-IJC7>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  10. Green A. R., Green V. L., White M. C., Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer. 1997 Sep 17;72(6):937–941. doi: 10.1002/(sici)1097-0215(19970917)72:6<937::aid-ijc3>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  11. Green V. L., Speirs V., Landolt A. M., Foy P. M., Atkin S. L. 17Beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomas. J Clin Endocrinol Metab. 1999 Apr;84(4):1340–1345. doi: 10.1210/jcem.84.4.5619. [DOI] [PubMed] [Google Scholar]
  12. Guengerich F. P. Characterization of human cytochrome P450 enzymes. FASEB J. 1992 Jan 6;6(2):745–748. doi: 10.1096/fasebj.6.2.1537465. [DOI] [PubMed] [Google Scholar]
  13. James V. H., McNeill J. M., Lai L. C., Newton C. J., Ghilchik M. W., Reed M. J. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids. 1987 Jul-Sep;50(1-3):269–279. doi: 10.1016/0039-128x(83)90077-6. [DOI] [PubMed] [Google Scholar]
  14. Jörnvall H., Persson B., Krook M., Atrian S., Gonzàlez-Duarte R., Jeffery J., Ghosh D. Short-chain dehydrogenases/reductases (SDR). Biochemistry. 1995 May 9;34(18):6003–6013. doi: 10.1021/bi00018a001. [DOI] [PubMed] [Google Scholar]
  15. Kurebayashi S., Miyashita Y., Hirose T., Kasayama S., Akira S., Kishimoto T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J Steroid Biochem Mol Biol. 1997 Jan;60(1-2):11–17. doi: 10.1016/s0960-0760(96)00175-6. [DOI] [PubMed] [Google Scholar]
  16. Labrie F., Luu-The V., Lin S. X., Labrie C., Simard J., Breton R., Bélanger A. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 1997 Jan;62(1):148–158. doi: 10.1016/s0039-128x(96)00174-2. [DOI] [PubMed] [Google Scholar]
  17. Lu Q., Nakmura J., Savinov A., Yue W., Weisz J., Dabbs D. J., Wolz G., Brodie A. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology. 1996 Jul;137(7):3061–3068. doi: 10.1210/endo.137.7.8770932. [DOI] [PubMed] [Google Scholar]
  18. Luu-The V., Zhang Y., Poirier D., Labrie F. Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):581–587. doi: 10.1016/0960-0760(95)00209-x. [DOI] [PubMed] [Google Scholar]
  19. Pasqualini J. R., Chetrite G., Blacker C., Feinstein M. C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab. 1996 Apr;81(4):1460–1464. doi: 10.1210/jcem.81.4.8636351. [DOI] [PubMed] [Google Scholar]
  20. Pasqualini J. R., Chetrite G., Nestour E. L. Control and expression of oestrone sulphatase activities in human breast cancer. J Endocrinol. 1996 Sep;150 (Suppl):S99–105. [PubMed] [Google Scholar]
  21. Peltoketo H., Isomaa V., Poutanen M., Vihko R. Expression and regulation of 17 beta-hydroxysteroid dehydrogenase type 1. J Endocrinol. 1996 Sep;150 (Suppl):S21–S30. [PubMed] [Google Scholar]
  22. Penning T. M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev. 1997 Jun;18(3):281–305. doi: 10.1210/edrv.18.3.0302. [DOI] [PubMed] [Google Scholar]
  23. Ray A., Prefontaine K. E., Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem. 1994 Apr 29;269(17):12940–12946. [PubMed] [Google Scholar]
  24. Reed M. J., Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev. 1997 Oct;18(5):701–715. doi: 10.1210/edrv.18.5.0314. [DOI] [PubMed] [Google Scholar]
  25. Santen R. J., Martel J., Hoagland M., Naftolin F., Roa L., Harada N., Hafer L., Zaino R., Santner S. J. Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab. 1994 Aug;79(2):627–632. doi: 10.1210/jcem.79.2.8045987. [DOI] [PubMed] [Google Scholar]
  26. Santner S. J., Feil P. D., Santen R. J. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab. 1984 Jul;59(1):29–33. doi: 10.1210/jcem-59-1-29. [DOI] [PubMed] [Google Scholar]
  27. Sasano H., Frost A. R., Saitoh R., Harada N., Poutanen M., Vihko R., Bulun S. E., Silverberg S. G., Nagura H. Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab. 1996 Nov;81(11):4042–4046. doi: 10.1210/jcem.81.11.8923858. [DOI] [PubMed] [Google Scholar]
  28. Simpson E. R., Mahendroo M. S., Means G. D., Kilgore M. W., Hinshelwood M. M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C. R., Michael M. D. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994 Jun;15(3):342–355. doi: 10.1210/edrv-15-3-342. [DOI] [PubMed] [Google Scholar]
  29. Sovak M. A., Bellas R. E., Kim D. W., Zanieski G. J., Rogers A. E., Traish A. M., Sonenshein G. E. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest. 1997 Dec 15;100(12):2952–2960. doi: 10.1172/JCI119848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Speirs V., Adams E. F., Rafferty B., White M. C. Interactive effects of interleukin-6, 17 beta-estradiol and progesterone on growth and 17 beta-hydroxysteroid dehydrogenase activity in human breast carcinoma cells. J Steroid Biochem Mol Biol. 1993 Jul;46(1):11–15. doi: 10.1016/0960-0760(93)90203-9. [DOI] [PubMed] [Google Scholar]
  31. Speirs V., Green A. R., Atkin S. L. Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8. J Steroid Biochem Mol Biol. 1998 Nov;67(3):267–274. doi: 10.1016/s0960-0760(98)00119-8. [DOI] [PubMed] [Google Scholar]
  32. Speirs V., Green A. R., Walton D. S., Kerin M. J., Fox J. N., Carleton P. J., Desai S. B., Atkin S. L. Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer. 1998 Dec;78(11):1421–1429. doi: 10.1038/bjc.1998.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Speirs V., Green A. R., White M. C. A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples. Int J Cancer. 1996 May 16;66(4):551–556. doi: 10.1002/(SICI)1097-0215(19960516)66:4<551::AID-IJC21>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  34. Speirs V., White M. C., Green A. R. Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell Dev Biol Anim. 1996 Feb;32(2):72–74. doi: 10.1007/BF02723036. [DOI] [PubMed] [Google Scholar]
  35. Tilson-Mallett N., Santner S. J., Feil P. D., Santen R. J. Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab. 1983 Dec;57(6):1125–1128. doi: 10.1210/jcem-57-6-1125. [DOI] [PubMed] [Google Scholar]
  36. Zhang Y., Word R. A., Fesmire S., Carr B. R., Rainey W. E. Human ovarian expression of 17 beta-hydroxysteroid dehydrogenase types 1, 2, and 3. J Clin Endocrinol Metab. 1996 Oct;81(10):3594–3598. doi: 10.1210/jcem.81.10.8855807. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES